Filter
1479
Filtered Results: 1479
Text search:
World
Health
Organization
(Regional
Office
for
South-East-Asia)
Featured
Recommendations
137
New Publications
388
Language
Document type
No document type
763
Studies & Reports
345
Guidelines
178
Manuals
76
Strategic & Response Plan
55
Training Material
16
Situation Updates
15
Fact sheets
13
Resource Platforms
9
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Global
97
South–East Asia Region
67
India
58
Myanmar / Burma
57
Nepal
44
Asia
42
Philippines
29
Bangladesh
26
Western and Central Europe
25
Indonesia
22
Africa
21
Cambodia
16
Ethiopia
14
Uganda
14
Western Pacific Region
14
Kenya
12
Thailand
12
Syria
11
Pakistan
10
Middle East and North Africa
10
Liberia
9
Afghanistan
9
Eastern Europe
9
Tanzania
8
South Africa
8
Zambia
7
Ukraine
7
Haiti
6
Mozambique
6
Sri Lanka
6
Yemen
6
Laos
6
Sierra Leone
5
Nigeria
5
Congo, Democratic Republic of
5
Ghana
5
Somalia
5
China
5
Rwanda
5
Malawi
5
East and Southern Africa
5
West and Central Africa
5
Latin America and the Carribbean
5
Russia
5
Zimbabwe
4
South Sudan
4
Sudan
4
Venezuela
4
Moldova
4
Vietnam
4
Burkina Faso
3
Senegal
3
Jordan
3
Papua New Guinea
3
Central African Republic
3
North Macedonia
3
Eastern Europe and Central Asia
3
Timor Leste/ East Timor
3
Iran
3
Georgia
3
Guinea
2
USA
2
Iraq
2
Lebanon
2
Turkey
2
Malaysia
2
Eswatini/ Swaziland
2
Madagascar
2
Mexico
2
North Korea
2
Albania
2
Kazakhstan
2
Belarus
2
Bosnia and Herzegovina
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Egypt
1
Singapore
1
Vanuatu
1
Argentina
1
Peru
1
Brazil
1
Hungary
1
Croatia
1
Ecuador
1
Greece
1
Lesotho
1
Other region
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Tajikistan
1
Qatar
1
Romania
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
358
Clinical Guidelines
161
Public Health
106
Women & Child Health
98
Key Resources
82
Capacity Building
26
Pharmacy & Technologies
18
Toolboxes
HIV
157
Mental Health
127
COVID-19
105
Planetary Health
97
TB
69
Rapid Response
60
NTDs
59
AMR
57
Global Health Education
50
Disability
49
Refugee
39
Caregiver
34
Natural Hazards
31
NCDs
27
Health Financing Toolbox
24
Conflict
23
Pharmacy
20
Zika
16
Ebola
11
Cholera
7
Specific Hazards
7
Polio
6
Typhoon
3
Social Ethics
1
Health Financing
1
Lack of trained providers capable of identifying which labouring women could benefit from assisted vaginal birth (AVB), and of safely performing the procedure is a major barrier for its use. Education and training are, therefore, considered crucial ...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses th...
This guideline provides global, evidence-informed recommendations on daily iron supplementation in infants and children, as a public-health intervention for the prevention of anaemia and iron defici...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting <... variations in the benefits and harms of chest imaging in different situations, remarks are provided to describe the circumstances under which each recommendation would benefit patients. The guide also includes implementation considerations for different settings, provides suggestions for impact monitoring and evaluation and identifies knowledge gaps meriting further research.
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring ... patients with HIV infection
The purpose of this handbook is to provide guidance to Member States on the practical aspects of maintaining sanitary standards at international borders at ports, airports, and ground crossings (points of entry) as set out in the International Health...
This volume contains monographs prepared at the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which met virtually online from 1 to 12 February 2021.
The detailed monographs in this volume summarize data on specific contaminants in food. Individual monographs ...
A all for global Action. The Oral Health Atlas. Second edition
WHO has issued a new recommendation on the length of bladder catheterization following surgical repair of a simple obstetric urinary fistula. Currently the length of catheterization is not standard and ranges from 5 to 42 days. The new guidance recommends a 7–10 day period of bladder catheterizati...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria tar...
The 2023 meeting of the WHO Clinical Consortium on Healthy Ageing (CCHA) was the group’s ninth gathering and took place in Geneva 5–7 December 2023. The meeting was structured around seven panels, with a series of technical presentations, plenary discussions and group work, and a final session o...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Practical Guidance for collaborative interventions
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World ... Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Ministry of Health & Family Welfare (MoHFW) identified AMR as one of the top 10 priorities for the ministry’s collaborative work with WHO. The National Health Policy 2017 identifies antimicrobial resistance as a problem and calls for effective action to address it. An international conference on AMR – “Combating Antimicrobial Resistance: A
Public Health Challenge and Priority”, was jointly organized by the Government of India and World Health Organization (WHO) in February 2016, which was attended by more than 350 participants. The Hon’ble Prime Minister, Shri Narendra Modi, and the Hon’ble Union Minister for Health, Shri J.P. Nadda have reiterated government’s commitment to tackle AMR.
A new reportshows that people in some 25 countries are set to face devasting levels of hunger in coming months due to the fallout from the COVID-19 pandemic. While the greatest concentration of need is in Africa, countries in Latin America and the Caribbean, and in the Middle ... and Asia – including middle-income countries - are also being ravaged by crippling levels of food insecurity
